Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Pfizer Inc (PFE) Made Protalix BioTherapeutics, Inc. (PLX) Jump 11% Today

Camber Capital filed an amended 13G on Protalix BioTherapeutics (NYSE:PLX) today disclosing a large increase in its position. Stephen Dubois’ hedge fund had 9 million shares of Protalix at the end of June. The amended filing shows a position of 14.8 million shares corresponding to a 15.59% stake in the company.

You can view the details of this filing here.

More interestingly just before the closing bell Pfizer (NYSE:PFE) also disclosed a large position in the stock which caused the stock to surge as high as $1.24 and close the day at $1.14. This corresponds to a daily gain of 10.7%. Pfizer now owns 5.7% of Protalix’s outstanding shares.

Follow Protalix Biotherapeutics Inc. (NYSEMKT:PLX)
Trade (NYSEMKT:PLX) Now!